Lessons in Digital Epidemiology from COTS-1: Coordinating Multicentre Research across 10 Countries Using Operational and Technology Innovation to Overcome Funding Deficiencies

References

• Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–1070. doi:10.1016/S0140-6736(14)60844-8.
   PubMed Web of Science ®Google Scholar
• Borgdorff MW, van Soolingen D. The re-emergence of tuberculosis: what have we learnt from molecular epidemiology? Clin Microbiol Infect. 2013;19(10):889–901. doi:10.1111/1469-0691.12253.
   PubMed Web of Science ®Google Scholar
• Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. Jama. 1999;282(7):677–686. doi:10.1001/jama.282.7.677.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global Burden of Disease Study. Lancet. 1997;349(9061):1269–1276. doi:10.1016/S0140-6736(96)07493-4.
   PubMed Web of Science ®Google Scholar
• World, 2014 HO. Global tuberculosis report. www.who.int/tb/publications/global_report/en. Published 2014. Accessed May 18, 2016.
   Google Scholar
• World, Organisatio H. Multi drug resistant tuberculosis (MDR-TB). www.who.int/tb/challenges/mdr/mdr_tb_factsheet.pdf?ua=1. Published 2014. Accessed May 18, 2016.
   Google Scholar
• Bouza E, Merino P, Muñoz P, Sanchez-Carrillo C, Yáñez J, Cortés C. Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore). 1997;76(1):53–61. doi:10.1097/00005792-199701000-00005.
   PubMed Web of Science ®Google Scholar
• Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol. 1967;64(4):742–748. doi:10.1016/0002-9394(67)92860-7.
   PubMed Web of Science ®Google Scholar
• Biswas J, Badrinath SS. Ocular morbidity in patients with active systemic tuberculosis. Int Ophthalmol. 1995;19(5):293–298. doi:10.1007/BF00130924.
   PubMed Web of Science ®Google Scholar
• Basu S, Monira S, Modi RR, et al. Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4(1):3. doi:10.1186/1869-5760-4-3.
   PubMedGoogle Scholar
• Gupta V, Gupta A, Rao NA. Intraocular tuberculosis–an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Gupta B, Gonzalez-Lopez JJ, et al. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):40–46. doi:10.3109/09273948.2014.986584.
   PubMed Web of Science ®Google Scholar
• Patel SS, Saraiya NV, Tessler HH, Goldstein DA. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol. 2013;131(6):752–758. doi:10.1001/jamaophthalmol.2013.71.
   PubMed Web of Science ®Google Scholar
• Lou SM, Montgomery PA, Larkin KL, et al. Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective. Ocul Immunol Inflamm. 2015;23(1):32–39. doi:10.3109/09273948.2014.994784.
   PubMed Web of Science ®Google Scholar
• Lou SM, Larkin KL, Winthrop K, Rosenbaum JT, Group USS. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm. 2015;23(1):25–31. doi:10.3109/09273948.2014.926936.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Control: A Short Update To The 2009 Report (World Health Organization, Geneva, 2009).
   Google Scholar
• Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore). 1984;63(1):25–55. doi:10.1097/00005792-198401000-00003.
   PubMed Web of Science ®Google Scholar
• Kannan B, Govindarajan K, Kummararaj S, Balaji V, Natarajapillai V. Retinal vasculitis in a patient with abdominal tuberculosis. Oman J Ophthalmol. 2010;3(2):81–85. doi:10.4103/0974-620X.64232.
   PubMedGoogle Scholar
• Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology. 2002;109(5):851–857. doi:10.1016/S0161-6420(02)00973-9.
   PubMedGoogle Scholar
• Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):14–24. doi:10.3109/09273948.2014.986582.
   PubMed Web of Science ®Google Scholar
• Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007;11(3):1–196. doi:10.3310/hta11030.
   PubMed Web of Science ®Google Scholar
• Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002;57(9):804–809. doi:10.1136/thorax.57.9.804.
   PubMed Web of Science ®Google Scholar
• Ang M, Wong WL, Kiew SY, Li X, Chee SP. Prospective head-to-head study comparing 2 commercial interferon gamma release assays for the diagnosis of tuberculous uveitis. Am J Ophthalmol. 2014;157(6):1306–1314; 1314.e1301-1304. doi:10.1016/j.ajo.2014.01.031.
   Google Scholar
• Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis. 2007;45(7):826–836. doi:10.1086/521106.
   PubMedGoogle Scholar
• Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. 2009;17(5):351–355. doi:10.3109/09273940903168688.
   PubMed Web of Science ®Google Scholar
• Pollock NR, Campos-Neto A, Kashino S, et al. Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol. 2008;29(9):878–886. doi:10.1086/590262.
   PubMedGoogle Scholar
• Sugita S, Ogawa M, Shimizu N, et al. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013;120(9):1761–1768. doi:10.1016/j.ophtha.2013.02.020.
   PubMed Web of Science ®Google Scholar
• Errera MH, Goldschmidt P, Batellier L, et al. Real-time polymerase chain reaction and intraocular antibody production for the diagnosis of viral versus toxoplasmic infectious posterior uveitis. Graefes Arch Clin Exp Ophthalmol. 2011;249(12):1837–1846. doi:10.1007/s00417-011-1724-7.
   PubMed Web of Science ®Google Scholar
• Gunasekeran DV. Association between noninfectious uveitis and psychological stress and the importance of holistic management: treating the patient with uveitis as an individual-not a disease. JAMA Ophthalmol. 2019;137(2):206–207. doi:10.1001/jamaophthalmol.2018.5910.
   PubMedGoogle Scholar
• Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the collaborative ocular tuberculosis study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171. doi:10.1167/iovs.18-24102.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Gunasekeran DV, Agarwal A, et al. The collaborative ocular tuberculosis study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis. Ocul Immunol Inflamm. 2018:1–11. doi:10.1080/09273948.2018.1489061.
   PubMed Web of Science ®Google Scholar
• Gunasekeran DV, Agrawal R, Agarwal A, et al. The collaborative ocular tuberculosis study (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis. Retina. 2019;39(8):1623–1630.
   Web of Science ®Google Scholar
• Agarwal A, Agrawal R, Gunasekaran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends. Ocul Immunol Inflamm. 2019;27(3):465–473.
   Web of Science ®Google Scholar
• Testi I, Agrawal R, Mahajan S, et al. Tubercular uveitis: nuggets from collaborative ocular tuberculosis study (COTS)-1. Ocul Immunol Inflamm. 2019;25:1–9.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Agarwal A, Jabs DA, et al. Standardization of nomenclature for ocular tuberculosis - results of collaborative ocular tuberculosis study (COTS) Workshop. Ocul Immunol Inflamm. 2019;10:1–11.
   PubMed Web of Science ®Google Scholar